BR9802163A - Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) - Google Patents
Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)Info
- Publication number
- BR9802163A BR9802163A BR9802163A BR9802163A BR9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A
- Authority
- BR
- Brazil
- Prior art keywords
- neoflavonoid
- substances
- treatment
- pharmaceutical compositions
- viral infections
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<B>COMPOSIçõES FARMACêUTICAS PARA O TRATAMENTO DE INFECçõES VIRAIS COMPREENDENDO SUBSTâNCIAS NEOFLAVONOIDES (4-ARILCULMARINAS)<D> A presente invenção diz respeito ao uso de substâncias neoflavonoides para a preparação de composições farmacêuticas adequadas em particular à aplicação tópica para a profilaxia e o tratamento de infecções provocadas pelo vírus do DNA, particularmente dos herpesvírus, ou seja, Herpes simplex (labial ou genital) e Herpes zoster.<B> PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS UNDERSTANDING NEOFLAVONOID SUBSTANCES (4-ARYCULMARINS) <D> The present invention relates to the use of neoflavonoid substances for the preparation of pharmaceutical compositions suitable in particular for topical application for the treatment and prophylaxis infections caused by the DNA virus, particularly herpesviruses, that is, Herpes simplex (labial or genital) and Herpes zoster.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9802163A BR9802163A (en) | 1998-05-29 | 1998-05-29 | Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9802163A BR9802163A (en) | 1998-05-29 | 1998-05-29 | Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9802163A true BR9802163A (en) | 2000-11-28 |
Family
ID=4069837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9802163A BR9802163A (en) | 1998-05-29 | 1998-05-29 | Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9802163A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858602B2 (en) | 2001-06-12 | 2005-02-22 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
-
1998
- 1998-05-29 BR BR9802163A patent/BR9802163A/en not_active Application Discontinuation
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858602B2 (en) | 2001-06-12 | 2005-02-22 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6916848B2 (en) | 2001-06-12 | 2005-07-12 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6924314B2 (en) | 2001-06-12 | 2005-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6946491B2 (en) | 2001-06-12 | 2005-09-20 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7012071B2 (en) | 2001-06-12 | 2006-03-14 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7041659B2 (en) | 2001-06-12 | 2006-05-09 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7045541B2 (en) | 2001-06-12 | 2006-05-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7101910B2 (en) | 2001-06-12 | 2006-09-05 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7329782B2 (en) | 2001-06-12 | 2008-02-12 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7547802B2 (en) | 2001-06-12 | 2009-06-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7863475B2 (en) | 2001-06-12 | 2011-01-04 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US8487000B2 (en) | 2001-06-12 | 2013-07-16 | Wellstat Therapertics Corporation | Compound for the treatment of metabolic disorders |
US8552062B2 (en) | 2001-06-12 | 2013-10-08 | Wellstat Therapeutics Corporation | Methods for the treatment of metabolic disorders such as diabetes |
US8604083B2 (en) | 2001-06-12 | 2013-12-10 | Wellstat Therapeutics Corporation | Method for the treatment of metabolic disorders |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9810745A (en) | Benzimidazole derivatives | |
BR9811121A (en) | Product, pharmaceutical composition, and use of a product | |
BR0211863A (en) | 1-alkyl or 1-cycloalkyltriazolo [4,3a] quinazolin-5-ones as phosphodiesterase inhibitors | |
BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
BR0316407A (en) | Antiviral nucleoside derivatives | |
PT80079B (en) | PROCESS FOR THE PREPARATION OF ANTI-VIRUS PHARMACEUTICAL COMPOSITIONS CONTAINING 2-DIETILAMINO-2 ', 6'-ACETOXYLID (LIDOCAINE) | |
HUP0102441A2 (en) | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals | |
UY26724A1 (en) | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUSES | |
BR112022026321A2 (en) | 1'-CYAN NUCLEOSIDE ANALOGS AND USES THEREOF | |
BR0013281A (en) | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation and use as antitumor agents | |
BR9806870A (en) | Compound, process for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, and use of a compound and process to prepare it. | |
BR9908015A (en) | Compositions comprising viruses and methods for concentrating virus preparations | |
YU7296A (en) | Novel pharmaceutical combination containing antivirus substance and one anti-inflamatory glucocorticoid | |
BRPI0411900B8 (en) | compounds and pharmaceutical compositions comprising them | |
DK169991D0 (en) | ANTIVIRAL RELATIONS | |
WO2000012534A3 (en) | A method of inhibiting formation of infectious herpes virus particles | |
BR9406509A (en) | Compounds for their preparation, use of the same pharmaceutical compositions and for prophylaxis and for the therapeutic treatment of malaria and diseases caused by leishmania toxoplasma gondil pneumocy | |
BRPI0413430A (en) | amide derivatives | |
DK449988D0 (en) | PHARMACEUTICAL PREPARATION WITH Double-stranded RNA | |
BR9802163A (en) | Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) | |
BR9916043A (en) | Compound, use of the same and its pharmaceutically acceptable salts, and pharmaceutical composition for the treatment of viral herpes infections in patients | |
BR9706938A (en) | Compound use of the same pharmaceutical formulation and processes to produce the compound and for the treatment or prevention of symptoms or effects of a viral infection in an infected mammal including a human | |
NO983090L (en) | Therapeutic compounds | |
BR9707400A (en) | Vaccines against gene 63 product of varicella zoster virus. | |
WO2002013764A3 (en) | Methods for treating subjects infected with a herpes virus or neisseria gonorrheae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |